US Stock MarketDetailed Quotes
RGC Regencell Bioscience
- 7.250
- +0.320+4.62%
Close Nov 7 16:00 ET
- 7.260
- +0.010+0.14%
Post 16:03 ET
94.34MMarket Cap-21969P/E (TTM)
7.420High6.930Low17.81KVolume7.250Open6.930Pre Close128.34KTurnover1.22%Turnover RatioLossP/E (Static)13.01MShares32.44052wk High11.47P/B10.60MFloat Cap3.03052wk Low--Dividend TTM1.46MShs Float59.000Historical High--Div YieldTTM7.07%Amplitude3.030Historical Low7.208Avg Price1Lot Size
Regencell Bioscience Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | -1.07%3.16B | 6.03%861.6M | -11.77%716M | -2.76%764.2M |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | -1.07%3.16B | 6.03%861.6M | -11.77%716M | -2.76%764.2M |
| Cost of revenue | -2.87%1.19B | 6.24%323.7M | -13.69%264.9M | -6.41%289.1M | ||||||
| Gross profit | 0.06%1.97B | 5.91%537.9M | -10.60%451.1M | -0.40%475.1M | ||||||
| Operating expense | -24.50%4.74M | -17.64%6.27M | 451.47%7.62M | 70.04%1.38M | 107.77%812.37K | 390.99K | 4.22%1.7B | 8.31%447.2M | 2.68%428.6M | 3.92%416.1M |
| Selling and administrative expenses | -21.77%3.67M | -8.10%4.69M | 441.40%5.11M | 121.30%943.04K | 161.81%426.14K | --162.77K | 0.23%513.4M | 0.23%128.8M | -0.70%126.9M | 1.57%129.2M |
| -Selling and marketing expense | -52.25%125.43K | 939.22%262.66K | 1,503.74%25.28K | -98.62%1.58K | 3,039.28%114.21K | --3.64K | ---- | ---- | ---- | ---- |
| -General and administrative expense | -19.96%3.55M | -12.81%4.43M | 439.62%5.08M | 201.81%941.46K | 96.03%311.93K | --159.13K | 0.23%513.4M | 0.23%128.8M | -0.70%126.9M | 1.57%129.2M |
| Research and development costs | -32.59%1.07M | -37.04%1.58M | 473.13%2.51M | 13.49%438.32K | 69.23%386.23K | --228.22K | ---- | ---- | ---- | ---- |
| Depreciation amortization depletion | ---- | ---- | ---- | ---- | ---- | ---- | 8.24%249.7M | 6.54%63.5M | 6.67%62.4M | 10.54%62.9M |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | 8.24%249.7M | 6.54%63.5M | 6.67%62.4M | 10.54%62.9M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | 3.33%912.6M | 6.98%246.7M | 0.49%227.4M | 3.72%222.8M |
| Operating profit | 24.50%-4.74M | 17.64%-6.27M | -451.47%-7.62M | -70.04%-1.38M | -107.77%-812.37K | -390.99K | -19.95%271.7M | -4.53%90.7M | -74.20%22.5M | -22.98%59M |
| Net non-operating interest income expense | 2.34%-125.1M | -0.64%-31.6M | 0.63%-31.7M | 3.72%-31.1M | ||||||
| Other net income (expense) | 76.73%373.51K | 810.37%211.34K | -32.94%23.22K | 34.62K | -4.40%67.3M | -49.75%10.1M | 104.94%33.2M | 16.10%13.7M | ||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | --17.8M | --0 | --17.8M | ---- |
| Earnings from equity interest | ---- | ---- | ---- | ---- | ---- | ---- | -18.03%24.1M | 25.89%-16.6M | -4.94%15.4M | 12.78%15M |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | -400.00%-24M | -241.38%-8.2M | -147.92%-11.9M | 20.00%-1.2M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | 400.00%24M | 241.38%8.2M | 147.92%11.9M | -20.00%1.2M |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 |
| Other non- operating income (expenses) | 76.73%373.51K | 810.37%211.34K | -32.94%23.22K | --34.62K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 28.03%-4.36M | 20.18%-6.06M | -463.92%-7.59M | -65.78%-1.35M | -107.77%-812.37K | -390.99K | -24.07%213.9M | -17.32%69.2M | -66.43%24M | -25.85%41.6M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | -8.63%101.6M | 35.23%40.3M | -56.85%12.6M | -20.00%18M |
| Net income | 28.03%-4.36M | 20.18%-6.06M | -463.92%-7.59M | -65.78%-1.35M | -107.77%-812.37K | -390.99K | -34.13%112.3M | -46.38%28.9M | -73.05%11.4M | -29.76%23.6M |
| Net income continuous Operations | 28.03%-4.36M | 20.18%-6.06M | -463.92%-7.59M | -65.78%-1.35M | -107.77%-812.37K | ---390.99K | -34.13%112.3M | -46.38%28.9M | -73.05%11.4M | -29.76%23.6M |
| Minority interest income | 67.90%-61.38K | -28.66%-191.2K | -148.61K | 0 | 0 | 0 | 0 | |||
| Net income attributable to the parent company | 26.73%-4.3M | 21.15%-5.87M | -452.88%-7.45M | -65.78%-1.35M | -107.77%-812.37K | -390.99K | -34.10%112.3M | -46.38%28.9M | -73.05%11.4M | -29.55%23.6M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 26.73%-4.3M | 21.15%-5.87M | -452.88%-7.45M | -65.78%-1.35M | -107.77%-812.37K | -390.99K | -34.10%112.3M | -46.38%28.9M | -73.05%11.4M | -29.55%23.6M |
| Basic earnings per share | 26.67%-0.33 | 22.41%-0.45 | -444.45%-0.58 | -65.78%-0.1065 | -107.77%-0.0643 | -0.0309 | -33.94%0.72 | -44.12%0.19 | -74.07%0.07 | -28.57%0.15 |
| Diluted earnings per share | 26.67%-0.33 | 22.41%-0.45 | -444.45%-0.58 | -65.78%-0.1065 | -107.77%-0.0643 | -0.0309 | -33.94%0.72 | -44.12%0.19 | -74.07%0.07 | -28.57%0.15 |
| Dividend per share | 0.00%0.88 | 0.00%0.22 | 0.00%0.22 | 0.00%0.22 | ||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data